Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,610 public trials 494 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of Subcutaneous Delivery of JNJ-54767414 (Daratumumab) in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT03242889

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • National Hospital Organization Shibukawa Medical Center Gunma, Japan
  • Nagoya City University Hospital Nagoya, Japan
  • Ogaki Municipal Hospital Ohgaki, Japan
  • Osaka University Hospital Osaka, Japan
View Trial Details
Completed

Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple Myeloma

NCT01794520

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Mayo Clinic - Scottsdale /ID# 75808 Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 170002 Little Rock, Arkansas, United States
  • Yale University /ID# 203704 New Haven, Connecticut, United States
  • Emory University, Winship Cancer Institute /ID# 74993 Atlanta, Georgia, United States
View all 29 locations
View Trial Details
Completed

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

NCT02726581

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 0020 Birmingham, Alabama, United States
  • Local Institution - 0160 Mobile, Alabama, United States
  • Local Institution - 0163 Fayetteville, Arkansas, United States
  • Local Institution - 0118 Bakersfield, California, United States
View all 121 locations
View Trial Details
Completed

A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma

NCT01564537

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of Arkansas Medical Sciences Little Rock, Arkansas, United States
  • Pacific Cancer Medical Center Inc Anaheim, California, United States
  • West Contra Costa Healthcare District Berkeley, California, United States
  • University of Florida Gainesville, Florida, United States
View all 24 locations
View Trial Details

Related conditions